← Browse by Condition
Medical Condition

proximal humeral fracture

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for proximal humeral fracture sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — proximal humeral fracture Clinical Trials

How many clinical trials are currently recruiting for proximal humeral fracture?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for proximal humeral fracture, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for proximal humeral fracture?
proximal humeral fracture research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a proximal humeral fracture clinical trial?
Eligibility criteria for proximal humeral fracture trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Exactech 1 trial
Zealand University Hospital 1 trial
Vanderbilt University Medical Center 1 trial

Recruiting Clinical Trials

NCT05703958
Recruiting
Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up
Enrollment
151 pts
Location
United States
Sponsor
Exactech
View Trial →
NCT06416618
Recruiting
Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years
Enrollment
60 pts
Location
Denmark, Finland
Sponsor
Zealand University Hospital
View Trial →
NCT03328650
Recruiting
Clinical Outcomes of the ALPS Proximal Humerus Plating System
Enrollment
150 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →

Related Conditions

fracture dislocation (1) non union fracture (1) shoulder fractures (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology